Vyndaqel OverviewTafamidis (trade name Vyndaqel) is a drug used to delay loss of peripheral nerve function in adults with familial amyloid polyneuropathy (FAP), an orphan disease. It works by stabilizing the protein, transthyretin, which is normally made up of four strands. In people with FAP these strands separate and form clumps that harm nerves. In May 2019, the FDA approved two preparations tafamidis meglumine and tafamidis, for the treatment of transthyretin mediated cardiomyopathy ...
Read more Vyndaqel Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tafamidis
Recent Vyndaqel Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 20mg, 61mg
NDC Database Records for Vyndaqel: (2 results)Sorted by National Drug Code
- 0069-1975 Vyndaqel 20 mg Oral Capsule, Liquid Filled by Pfizer Laboratories Div Pfizer Inc
- 0069-8729 Vyndaqel by Pfizer Labs Division of Pfizer Inc.